Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of the ...
After a rough regulatory start to the year, India’s Aurobindo Pharma is charting plans for growth. The Hyderabad-based generics juggernaut will plow 3 billion Indian rupees (about $37.7 million) into ...
SMU Office of Research & Tech Transfer – What is the state of financial wellness of Singaporean youth? Speaking to the Office of Research & Tech Transfer, SMU Assistant Professor of Finance (Education ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results